Evaxion Biotech A/S (EVAX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 24.9M | 10.57M | 18.18M | 17.84M | 8.77M | 4.58M | 10.7M | 11.73M | 8.35M | 6.85M | 11.37M | 10.24M |
| Cash & Short-Term Investments | 23.23M | 10.57M | 14.75M | 17.84M | 5.05M | 4.58M | 7.99M | 11.73M | 5.58M | 2.6M | 7.12M | 10.24M |
| Cash Only | 23.23M | 10.57M | 14.75M | 17.84M | 5.05M | 4.58M | 7.99M | 11.73M | 5.58M | 2.6M | 7.12M | 10.24M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.05M | 0 | 864.02K | 0 | 1.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | 2.13K | - | 1.4K | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | -10.57M | -18 | -17.84M | 900K | -4.58M | 790K | -11.73M | 1.07M | 898K | 917K | -10.24M |
| Total Non-Current Assets | 3.51M | 19.16M | 4.27M | 7.4M | 3.72M | 10.61M | 4.53M | 10.92M | 4.54M | 5.09M | 5.39M | 10.25M |
| Property, Plant & Equipment | 3.32M | 0 | 3.62M | 0 | 3.51M | 0 | 3.9M | 0 | 4.34M | 4.31M | 4.58M | 0 |
| Fixed Asset Turnover | - | - | 0.01x | - | 0.03x | - | 0.04x | - | 0.02x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 464.01K | 0 | 44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 185K | 19.16M | 184.99K | 7.4M | 162K | 10.61M | 628K | 10.92M | 196K | 777K | 804K | 10.25M |
| Total Assets | 28.41M | 29.74M | 22.45M | 25.24M | 12.48M | 15.19M | 15.23M | 22.65M | 12.89M | 11.94M | 16.75M | 20.49M |
| Asset Turnover | - | 0.29x | 0.00x | - | 0.01x | 0.20x | 0.01x | 0.00x | 0.01x | - | - | - |
| Asset Growth % | 127.53% | 95.83% | 47.39% | 11.41% | -3.13% | 27.16% | -9.09% | 10.57% | -41.48% | -56.49% | -50.73% | -50.13% |
| Total Current Liabilities | 4.26M | 0 | 5.32M | 0 | 4.37M | 0 | 3.82M | 0 | 7.08M | 4.69M | 4.05M | 0 |
| Accounts Payable | 2.19M | 0 | 2.5M | 0 | 2.97M | 0 | 2.56M | 0 | 2.69M | 2.61M | 1.69M | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 190K | 0 | 184K | 0 | 159K | 0 | 158K | 0 | 159K | 150K | 152K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 415.99K | 0 | 1.13M | 0 | 67K | 0 | 786K | 0 | 3.02M | 1.62M | 1.9M | 0 |
| Current Ratio | 5.85x | - | 3.42x | - | 2.01x | - | 2.80x | - | 1.18x | 1.46x | 2.81x | - |
| Quick Ratio | 5.85x | - | 3.42x | - | 2.01x | - | 2.80x | - | 1.18x | 1.46x | 2.81x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.11M | 13.14M | 10.9M | 14.92M | 9.77M | 15.11M | 10.16M | 20.05M | 10.53M | 9.99M | 10.17M | 13.91M |
| Long-Term Debt | 5.35M | 0 | 9.03M | 0 | 8.01M | 0 | 8.26M | 0 | 8.49M | 7.99M | 8.08M | 0 |
| Capital Lease Obligations | 1.61M | 0 | 1.71M | 0 | 1.62M | 0 | 1.75M | 0 | 1.9M | 1.86M | 1.95M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 158K | 13.14M | 158K | 14.92M | 141K | 15.11M | 145K | 20.05M | 149K | 143K | 147K | 13.91M |
| Total Liabilities | 11.37M | 13.14M | 16.22M | 14.92M | 14.14M | 15.11M | 13.98M | 20.05M | 17.62M | 14.68M | 14.22M | 13.91M |
| Total Debt | 7.5M | 0 | 11.28M | 0 | 10.1M | 0 | 10.49M | 0 | 10.87M | 10.31M | 10.49M | 0 |
| Net Debt | -15.73M | -10.57M | -3.46M | -17.84M | 5.05M | -4.58M | 2.5M | -11.73M | 5.29M | 7.7M | 3.37M | -10.24M |
| Debt / Equity | 0.44x | - | 1.81x | - | - | - | 8.37x | - | - | - | 4.14x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -1.85x | - | - | - | - | - | -9.60x | - | - | - | - |
| Interest Coverage | -7.38x | 4.20x | -19.85x | -3.46x | -12.33x | -4.28x | -27.43x | 4.97x | -27.32x | -31.26x | -25.73x | -18.74x |
| Total Equity | 17.04M | 16.6M | 6.23M | 10.32M | -1.65M | 74K | 1.25M | 2.6M | -4.73M | -2.73M | 2.54M | 6.58M |
| Equity Growth % | 1131.4% | 22331.08% | 396.89% | 296.35% | 65.07% | 102.71% | -50.57% | -60.4% | -156.96% | -120.18% | -87.42% | -75.08% |
| Book Value per Share | 2.66 | 15.02 | 5.63 | 9.34 | -1.54 | 0.05 | 0.93 | 2.23 | -6.92 | -3.95 | 3.75 | 10.20 |
| Total Shareholders' Equity | 17.04M | 16.6M | 6.23M | 10.32M | -1.65M | 74K | 1.25M | 2.6M | -4.73M | -2.73M | 2.54M | 6.58M |
| Common Stock | 15.79M | 13.81M | 11.82M | 11.82M | 10.52M | 8.73M | 8.24M | 7.96M | 5.9M | 4.42M | 4.39M | 4.22M |
| Retained Earnings | -126.24M | -127.32M | -124.95M | -120.11M | -118.54M | -114.9M | -112.97M | -112.03M | -107.97M | -89.76M | -84.26M | -78.72M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 6.76M | 130.11M | -3.08M | 118.61M | -3.6M | 106.25M | 10.1M | 106.67M | 9.89M | -3.53M | -3.62M | 81.08M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |